Your browser doesn't support javascript.
loading
A real-world comparison of cardiovascular, medical and costs outcomes in new users of SGLT2 inhibitors versus GLP-1 agonists.
Poonawalla, Insiya B; Bowe, Andy T; Tindal, Michael C; Meah, Yunus A; Schwab, Phil.
Afiliación
  • Poonawalla IB; Humana Healthcare Research, Inc., Louisville, KY, United States. Electronic address: IPoonawalla@humana.com.
  • Bowe AT; Humana Healthcare Research, Inc., Louisville, KY, United States.
  • Tindal MC; Humana Inc., Louisville, KY, United States.
  • Meah YA; Humana Inc., Louisville, KY, United States.
  • Schwab P; Humana Healthcare Research, Inc., Louisville, KY, United States.
Diabetes Res Clin Pract ; 175: 108800, 2021 May.
Article en En | MEDLINE | ID: mdl-33845052

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptido 1 Similar al Glucagón / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Res Clin Pract Asunto de la revista: ENDOCRINOLOGIA Año: 2021 Tipo del documento: Article Pais de publicación: Irlanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptido 1 Similar al Glucagón / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Res Clin Pract Asunto de la revista: ENDOCRINOLOGIA Año: 2021 Tipo del documento: Article Pais de publicación: Irlanda